He, Qiangqiang
Wei, Yaping
Zhu, Hehao
Liang, Qiongyue
Chen, Ping
Li, Shuqun
Song, Yun
Liu, Lishun
Wang, Binyan
Xu, Xiping
Dong, Yuhan
Funding for this research was provided by:
the National Key Research and Development Program (2022YFC2009600, 2022YFC2009601)
the Department of Science and Technology of Guangdong Province, and the Development and Reform Commission of Shenzhen Municipality (XMHT20220104055)
National Key Research and Development Program of China (2018ZX09739010, 2018ZX09301034003)
the Department of Science and Technology of Guangdong Province, Guangdong Key Laboratory of H-type Hypertension and Stroke Precision Prevention Research and Development Enterprise (2020B121202010)
Science, Technology and Innovation Committee of Shenzhen (JSGG20180703155802047, JSGG20201103153807021, KCXFZ20211020163801002)
Article History
Received: 27 June 2023
Accepted: 29 March 2024
First Online: 2 April 2024
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Institute of Biomedicine, Anhui Medical University, Hefei, China.
: Informed consent was obtained from all subjects involved in the study.
: The authors have no relevant financial or non-financial interests to disclose.